Loading stock data…
HCAT
$1.45+0.20 (+16.00%)
Market ClosedLast close May 1
Health Catalyst, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Health Catalyst, Inc. in the Healthcare sector is trading at $1.45. The stock is currently near its 52-week low of $0.95, remaining 41.1% below its 200-day moving average. Technical signals show overbought RSI of 75 and bullish MACD crossover, explaining why HCAT maintains its current current market pressure. The Whystock Score of 10/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Overbought levels (RSI 75) — risk of consolidation or pullback
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$1.45
Potential Upside
5%
Whystock Fair Value$1.52
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus7 analysts
Hold
Mean target$1.96+35.5%
Range$1.00 – $3.00
Fundamentals
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments: Technology and Professional Services. It offers ignite data and analytics platform that ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$97.87M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.81
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-72.41%
Volume
Today's trading volume
385,458
Recent News
3 of Wall Street’s Favorite Stocks We Think Twice About
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
April 2026's Top Penny Stocks To Watch
Over the last 7 days, the United States market has risen by 1.3%, and in the past year, it has climbed an impressive 35%, with earnings forecasted to grow annually by 16%. In light of these market conditions, investors may find value in exploring penny stocks—typically smaller or newer companies that can offer unique opportunities. While the term "penny stocks" might seem outdated, they remain relevant as investment options for those seeking affordability and potential growth when backed by...
American Well (AMWL) Surges 13.3%: Is This an Indication of Further Gains?
American Well (AMWL) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Health Catalyst and ZoomInfo Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after markets benefited from a "risk-on" sentiment fueled by potential peace negotiations between the U.S. and Iran.
Health Catalyst, Commerce, DocuSign, Unity, and Workiva Shares Plummet, What You Need To Know
A number of stocks fell in the morning session after reports of a ceasefire breach in the Middle East spiked market volatility as fears grew that a fragile U.S.-Iran truce would unravel.